Back to Search
NAROTHAM THUDI, MD
MD
Hematology & Oncology Physician
NPI: 1861401788IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
L9930(TX)
Education
OTHER
Class of 1993
Research & Publications (12)
The role of Dickkopf-1 in bone development, homeostasis, and disease.
PMID 18687985·Blood·2009
6-review
A single-dose, randomized, open-label, two-period crossover bioequivalence study comparing a fixed-dose pediatric combination of lamivudine and stavudine tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
PMID 19338141·Arzneimittelforschung·2009
2-rct
Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions.
PMID 18729185·Int J Cancer·2008
7-preclinical
Bioequivalence studies of tacrolimus capsule under fasting and fed conditions in healthy male and female subjects.
PMID 18589558·Arzneimittelforschung·2008
4-observational
Pharmacodynamic equivalence of two orlistat capsule formulations in healthy volunteers under fed conditions.
PMID 18541129·Int J Clin Pharmacol Ther·2008
2-rct
Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions.
PMID 18461562·Prostate·2008
7-preclinical
A bioequivalence study comparing two formulations of lopinavir/ritonavir capsules.
PMID 18397695·Int J Clin Pharmacol Ther·2008
2-rct
Expression of parathyroid hormone-related protein during immortalization of human peripheral blood mononuclear cells by HTLV-1: implications for transformation.
PMID 18541021·Retrovirology·2008
8-other
NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imaging.
PMID 19178662·Vet Comp Oncol·2008
7-preclinical
A novel bioluminescent mouse model and effective therapy for adult T-cell leukemia/lymphoma.
PMID 18089816·Cancer Res·2007
7-preclinical
Pharmacokinetics of lamivudine, zidovudine, and nevirapine administered as a fixed-dose combination formulation versus coadministration of the individual products.
PMID 17962426·J Clin Pharmacol·2007
4-observational
New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft.
PMID 16683269·Prostate·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2021 N MACARTHUR BLVD, SUITE 400
IRVING, TX 75061 - Phone
- (972) 256-3537
Quick Facts
- NPI
- 1861401788
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 12
Are you this provider?
Claim Your Profile